• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻素 1 型受体在存在Δ9-四氢大麻酚的情况下与大麻二酚的结合和负变构调节:一项计算机研究。

Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study.

机构信息

Pharmacy Department, Faculty of Chemistry, Pontificia Universidad Católica de Chile, Santiago, Chile.

Organic Chemistry Department, Faculty of Chemistry, Pontificia Universidad Católica de Chile, Santiago, Chile.

出版信息

PLoS One. 2019 Jul 23;14(7):e0220025. doi: 10.1371/journal.pone.0220025. eCollection 2019.

DOI:10.1371/journal.pone.0220025
PMID:31335889
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6650144/
Abstract

Recent evidence has raised in discussion the possibility that cannabidiol can act as a negative allosteric modulator of the cannabinoid type 1 receptor. Here we have used computational methods to study the modulation exerted by cannabidiol on the effects of delta-9-tetrahydrocannabinol in the cannabinoid receptor type 1 and the possibility of direct receptor blockade. We propose a putative allosteric binding site that is located in the N-terminal region of receptor, partially overlapping the orthosteric binding site. Molecular dynamics simulations reveled a coordinated movement involving the outward rotation of helixes 1 and 2 and subsequent expansion of the orthosteric binding site upon cannabidiol binding. Finally, changes in the cytoplasmic region and high helix 8 mobility were related to impaired receptor internalization. Together, these results offer a possible explanation to how cannabidiol can directly modulate effects of delta-9-tetrahydrocannabinol on the cannabinoid receptor type 1.

摘要

最近的证据引发了讨论,即大麻二酚可能作为大麻素 1 型受体的负变构调节剂发挥作用。在这里,我们使用计算方法研究了大麻二酚对大麻素受体 1 中 δ-9-四氢大麻酚的作用的调制以及直接受体阻断的可能性。我们提出了一个假定的变构结合位点,该位点位于受体的 N 端区域,部分重叠于正位结合位点。分子动力学模拟揭示了涉及螺旋 1 和 2 的向外旋转以及大麻二酚结合后正位结合位点的后续扩张的协调运动。最后,细胞质区域的变化和高螺旋 8 的流动性与受体内化受损有关。总之,这些结果提供了一种可能的解释,即大麻二酚如何直接调节大麻素 1 型受体上 δ-9-四氢大麻酚的作用。

相似文献

1
Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study.大麻素 1 型受体在存在Δ9-四氢大麻酚的情况下与大麻二酚的结合和负变构调节:一项计算机研究。
PLoS One. 2019 Jul 23;14(7):e0220025. doi: 10.1371/journal.pone.0220025. eCollection 2019.
2
Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol-A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling.大麻素 CB1 受体的变构调节:大麻二酚 - 对 N 端结构域和变构-变构偶联的分子建模研究。
Molecules. 2021 Apr 23;26(9):2456. doi: 10.3390/molecules26092456.
3
Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.大麻二酚和大麻二酚-二甲基庚基在大麻素受体 1 型和 2 型上的变构和正构药理学。
Br J Pharmacol. 2019 May;176(10):1455-1469. doi: 10.1111/bph.14440. Epub 2018 Aug 10.
4
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor.大麻二酚是大麻素CB1受体的负变构调节剂。
Br J Pharmacol. 2015 Oct;172(20):4790-805. doi: 10.1111/bph.13250. Epub 2015 Oct 13.
5
Assessing Allosteric Modulation of CB at the Receptor and Cellular Levels.在受体和细胞水平评估大麻素的变构调节作用。
Methods Enzymol. 2017;593:317-342. doi: 10.1016/bs.mie.2017.05.002. Epub 2017 Jul 5.
6
Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.大麻素受体 2 的负变构调节剂:正构激动剂存在下的蛋白建模、结合位点鉴定和分子动力学模拟。
J Biomol Struct Dyn. 2020 Jan;38(1):32-47. doi: 10.1080/07391102.2019.1567384. Epub 2019 Feb 5.
7
In silico mapping of allosteric ligand binding sites in type-1 cannabinoid receptor.1型大麻素受体变构配体结合位点的计算机模拟定位
Biotechnol Appl Biochem. 2018 Jan;65(1):21-28. doi: 10.1002/bab.1589. Epub 2018 Jan 3.
8
Dual allosteric and orthosteric pharmacology of synthetic analog cannabidiol-dimethylheptyl, but not cannabidiol, on the cannabinoid CB receptor.合成类似物大麻二酚-二甲基庚基对大麻素 CB 受体的双重变构和正构药理学,而不是大麻二酚。
Biochem Pharmacol. 2023 Dec;218:115924. doi: 10.1016/j.bcp.2023.115924. Epub 2023 Nov 14.
9
Design of Negative and Positive Allosteric Modulators of the Cannabinoid CB Receptor Derived from the Natural Product Cannabidiol.基于天然产物大麻二酚设计大麻素 CB1 受体的负变构调节剂和正变构调节剂。
J Med Chem. 2021 Jul 8;64(13):9354-9364. doi: 10.1021/acs.jmedchem.1c00561. Epub 2021 Jun 23.
10
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Variety: Δ-Tetrahydrocannabutol, the Butyl Homologue of Δ-Tetrahydrocannabinol.从药用品种中分离出对人类 CB1 受体具有高亲和力的大麻素:Δ-四氢大麻醇的丁基同系物Δ-四氢大麻丁醇。
J Nat Prod. 2020 Jan 24;83(1):88-98. doi: 10.1021/acs.jnatprod.9b00876. Epub 2019 Dec 31.

引用本文的文献

1
The Acute Effects of Cannabidiol on Physiological and Subjective Responses to Endurance Exercise: A Dose-Ranging Randomised Controlled Crossover Trial.大麻二酚对耐力运动的生理和主观反应的急性影响:一项剂量范围随机对照交叉试验。
Sports Med Open. 2025 Aug 21;11(1):96. doi: 10.1186/s40798-025-00895-w.
2
Psychoactive substances: novel molecular insights and therapeutic potential for Alzheimer's disease.精神活性物质:对阿尔茨海默病的新分子见解及治疗潜力
Transl Neurodegener. 2025 Jul 25;14(1):38. doi: 10.1186/s40035-025-00498-1.
3
UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Epilepsy.

本文引用的文献

1
CASTp 3.0: computed atlas of surface topography of proteins.CASTp 3.0:蛋白质表面形貌计算图谱。
Nucleic Acids Res. 2018 Jul 2;46(W1):W363-W367. doi: 10.1093/nar/gky473.
2
Assessing the real-time activation of the cannabinoid CB1 receptor and the associated structural changes using a FRET biosensor.使用 FRET 生物传感器评估大麻素 CB1 受体的实时激活及其相关结构变化。
Int J Biochem Cell Biol. 2018 Jun;99:114-124. doi: 10.1016/j.biocel.2018.04.003. Epub 2018 Apr 5.
3
Multiple Binding Sites Contribute to the Mechanism of Mixed Agonistic and Positive Allosteric Modulators of the Cannabinoid CB1 Receptor.
英国医用大麻注册:癫痫的临床结果分析
Brain Behav. 2025 Apr;15(4):e70490. doi: 10.1002/brb3.70490.
4
Identification of a Cannabinoid Receptor 2 Allosteric Site Using Computational Modeling and Pharmacological Analysis.利用计算建模和药理学分析鉴定大麻素受体2变构位点
ACS Pharmacol Transl Sci. 2025 Jan 28;8(2):423-434. doi: 10.1021/acsptsci.4c00547. eCollection 2025 Feb 14.
5
Acute and prolonged toxicity assessment of extract in rodents and lagomorphs.提取物在啮齿动物和兔形目动物中的急性和长期毒性评估。
Toxicol Rep. 2025 Jan 25;14:101918. doi: 10.1016/j.toxrep.2025.101918. eCollection 2025 Jun.
6
Current and Potential Use of Biologically Active Compounds Derived from L. in the Treatment of Selected Diseases.来源于L.的生物活性化合物在特定疾病治疗中的当前及潜在应用。
Int J Mol Sci. 2024 Nov 27;25(23):12738. doi: 10.3390/ijms252312738.
7
Pharmacology of Non-Psychoactive Phytocannabinoids and Their Potential for Treatment of Cardiometabolic Disease.非精神活性植物大麻素的药理学及其治疗心血管代谢疾病的潜力。
Handb Exp Pharmacol. 2025;287:61-93. doi: 10.1007/164_2024_731.
8
Systematic review and meta-analysis on the effects of chronic peri-adolescent cannabinoid exposure on schizophrenia-like behaviour in rodents.关于慢性青春期周围大麻素暴露对啮齿动物精神分裂症样行为影响的系统评价和荟萃分析。
Mol Psychiatry. 2025 Jan;30(1):285-295. doi: 10.1038/s41380-024-02668-5. Epub 2024 Aug 2.
9
CBD and THC in Special Populations: Pharmacokinetics and Drug-Drug Interactions.特殊人群中的大麻二酚(CBD)和四氢大麻酚(THC):药代动力学与药物相互作用
Pharmaceutics. 2024 Apr 1;16(4):484. doi: 10.3390/pharmaceutics16040484.
10
analyses of the involvement of GPR55, CB1R and TRPV1: response to THC, contribution to temporal lobe epilepsy, structural modeling and updated evolution.对GPR55、CB1R和TRPV1参与情况的分析:对四氢大麻酚的反应、对颞叶癫痫的作用、结构建模及最新进化情况
Front Neuroinform. 2024 Feb 7;18:1294939. doi: 10.3389/fninf.2024.1294939. eCollection 2024.
多个结合位点有助于大麻素 CB1 受体的混合激动剂和正变构调节剂的作用机制。
Angew Chem Int Ed Engl. 2018 Mar 1;57(10):2580-2585. doi: 10.1002/anie.201708764. Epub 2018 Feb 2.
4
In silico mapping of allosteric ligand binding sites in type-1 cannabinoid receptor.1型大麻素受体变构配体结合位点的计算机模拟定位
Biotechnol Appl Biochem. 2018 Jan;65(1):21-28. doi: 10.1002/bab.1589. Epub 2018 Jan 3.
5
Crystal structures of agonist-bound human cannabinoid receptor CB.激动剂结合的人源大麻素受体CB的晶体结构
Nature. 2017 Jul 27;547(7664):468-471. doi: 10.1038/nature23272. Epub 2017 Jul 5.
6
Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor.变构调节:一种靶向大麻素CB1受体的替代方法。
Med Res Rev. 2017 May;37(3):441-474. doi: 10.1002/med.21418. Epub 2016 Nov 23.
7
High-resolution crystal structure of the human CB1 cannabinoid receptor.人类CB1大麻素受体的高分辨率晶体结构。
Nature. 2016 Dec 22;540(7634):602-606. doi: 10.1038/nature20613. Epub 2016 Nov 16.
8
Crystal Structure of the Human Cannabinoid Receptor CB.人类大麻素受体CB的晶体结构
Cell. 2016 Oct 20;167(3):750-762.e14. doi: 10.1016/j.cell.2016.10.004.
9
Diverse activation pathways in class A GPCRs converge near the G-protein-coupling region.A类G蛋白偶联受体(GPCRs)中的多种激活途径在靠近G蛋白偶联区域处汇聚。
Nature. 2016 Aug 25;536(7617):484-7. doi: 10.1038/nature19107. Epub 2016 Aug 15.
10
Cannabinoid receptor type-1: breaking the dogmas.1型大麻素受体:打破教条
F1000Res. 2016 May 24;5. doi: 10.12688/f1000research.8245.1. eCollection 2016.